Treatment of childhood idiopathic thrombocytopenic purpura.
Ozsoylu
S
S
D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D011241:Prednisone / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D011696:Purpura, Thrombocytopenic / Q000097:blood / Q000188:drug therapy* / Q000628:therapy*
D016756:Immunoglobulins, Intravenous; D011241:Prednisone; D008775:Methylprednisolone